Digital health giant Sword Health will continue its expansion into the behavioral health sector with the acquisition of Headspace, effective Sept. 14, according to public documents.
New York-based Sword Health got its start in musculoskeletal care but has since expanded into other parts of healthcare, including women’s health, cardiometabolic care and mental health. While details of the deal itself are presently sparse, it represents one of the most significant digital health deals in the behavioral health space.
San Francisco-based Headspace offers mental health services of several types — including therapy, coaching, wellness apps and EAP services.
Requests for comment sent to both companies have not yet been returned. This story may be updated.
Both companies have a heavy focus on business-to-business (B2B) contracting. Sword Health says on its website that it focuses on working with employers, health plans, labor unions, and health systems. Its services are offered via an AI-powered platform. Headspace offers a direct-to-consumer option, but it too focuses on employers and health plans. Headspace employs about 598 people, including 418 full-time staffers.
The documents state that clinical services will not be reduced because of the merger. However, “the combined company anticipates that there may be reductions in corporate staff where functions are duplicative between the two organizations,” the documents, which were first spotted by Healthcare Dealflow, state.
“The aggregate purchase price for the transaction is a cash payment subject to customary post-signing adjustments, including adjustments for closing cash, indebtedness, transaction expenses, and net working capital,” the documents state. “The merger agreement provides for an estimated closing adjustment followed by a customary post-closing true-up.”
Sword Health has previously noted that mental health was part of its larger company roadmap that would help position it for a possible IPO in 2028. The company has already released its “Mind” offering – which integrates an AI therapist, a wearable device to detect depression and anxiety and incorporates input from clinicians 24/7 for responsive care. It has also hinted at growing its serious mental illness (SMI) offerings through partnerships and acquisitions.
“I want to IPO when we have the mental health solution itself right because I want to be focused right now on really making sure that we build a valuable mental health solution,” Virgilio Bento, Sword Health CEO, previously told Behavioral Health Business. “I don’t want to be distracted by going public. We are quite focused on mental health and that’s why an IPO is not our goal in the short term.”
Sword Health was founded in 2015. Headspace, as it is known today, was born of a merger with the meditation app of the same name and Ginger Health, a digital clinical offering, in October 2021. At that time, the combined company was valued at $3 billion. It’s not yet clear what the valuation of Sword Health-Headspace is. That said, the valuation is likely to be high. A little over a year ago, Sword Health raised $40 million on a valuation of about $4 billion. As part of that funding round, the company also launched its existing mental health offering.
Headspace being acquired may be something of a surprise. Pitchbook had the company pegged as potentially going for an IPO, along with Spring Health. Spring Health announced it would acquire Alma, a digital therapy platform, near the beginning of 2026. It closed the deal on May 1.
Sword Health has raised an estimated $495 million, while Headspace has raised an estimated $321 million, according to Crunchbase.